Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · IEX Real-Time Price · USD

41.39

-0.55 (-1.31%)

At close: May 17, 2024, 4:00 PM

41.25

-0.14 (-0.34%)

After-hours: May 17, 2024, 4:33 PM EDT

Vera Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	23.79	21.91	11.92	4.04	4.41
Research & Development	78.23	68.99	22.48	45.21	7.29
Other Operating Expenses	0	0	0	3	0.26
Operating Expenses	102.01	90.9	34.4	52.24	11.96
Operating Income	-102.01	-90.9	-34.4	-52.24	-11.96
Interest Expense / Income	3.79	0.99	0.02	0.17	0.05
Other Expense / Income	-9.81	-2.84	-1.81	1.01	-0.16
Pretax Income	-95.99	-89.06	-32.61	-53.41	-11.85
Income Tax	0	0	0	0	0
Net Income	-95.99	-89.06	-32.61	-53.41	-11.85
Shares Outstanding (Basic)	43	27	13	0	0
Shares Outstanding (Diluted)	43	27	13	0	0
Shares Change	60.73%	97.76%	4099.14%	8.34%	-
EPS (Basic)	-2.25	-3.35	-2.43	-166.93	-40.14
EPS (Diluted)	-2.25	-3.35	-2.43	-166.93	-40.14
Free Cash Flow	-92.24	-67.66	-23.71	-34.85	-10.41
Free Cash Flow Per Share	-2.16	-2.55	-1.76	-108.92	-35.26
EBITDA	-94.07	-86.64	-32.41	-53	-11.29
Depreciation & Amortization	-1.86	1.43	0.18	0.25	0.51
EBIT	-92.2	-88.06	-32.59	-53.25	-11.8

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).